home / stock / cnst / cnst quote
Last: | $33.99 |
---|---|
Change Percent: | 0.06% |
Open: | $33.98 |
Close: | $33.99 |
High: | $34.05 |
Low: | $33.97 |
Volume: | 1,283,908 |
Last Trade Date Time: | 07/14/2021 04:42:26 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$33.99 | $33.98 | $33.99 | $34.05 | $33.97 | 1,283,908 | 07-14-2021 |
$33.97 | $33.97 | $33.97 | $34.01 | $33.97 | 504,439 | 07-13-2021 |
$33.97 | $33.96 | $33.97 | $34.01 | $33.95 | 1,124,912 | 07-12-2021 |
$33.96 | $33.94 | $33.96 | $33.97 | $33.94 | 531,580 | 07-09-2021 |
$33.95 | $33.9 | $33.95 | $33.97 | $33.89 | 674,056 | 07-08-2021 |
$33.95 | $33.95 | $33.95 | $33.97 | $33.92 | 595,499 | 07-07-2021 |
$33.99 | $33.94 | $33.99 | $34 | $33.9 | 715,862 | 07-06-2021 |
$33.9 | $33.92 | $33.9 | $33.93 | $33.9 | 422,756 | 07-05-2021 |
$33.9 | $33.92 | $33.9 | $33.93 | $33.9 | 422,756 | 07-02-2021 |
$33.92 | $33.89 | $33.92 | $33.95 | $33.88 | 995,848 | 07-01-2021 |
$33.8 | $33.82 | $33.8 | $33.85 | $33.78 | 1,010,816 | 06-30-2021 |
$33.84 | $33.81 | $33.84 | $33.85 | $33.81 | 284,273 | 06-29-2021 |
$33.85 | $33.82 | $33.85 | $33.85 | $33.8 | 626,556 | 06-28-2021 |
$33.81 | $33.83 | $33.81 | $33.85 | $33.65 | 2,294,826 | 06-25-2021 |
$33.8 | $33.76 | $33.8 | $33.85 | $33.76 | 625,306 | 06-24-2021 |
$33.76 | $33.75 | $33.76 | $33.82 | $33.75 | 956,273 | 06-23-2021 |
$33.75 | $33.78 | $33.75 | $33.83 | $33.7 | 1,408,113 | 06-22-2021 |
$33.8 | $33.76 | $33.8 | $33.85 | $33.74 | 771,307 | 06-21-2021 |
$33.76 | $33.77 | $33.76 | $33.82 | $33.725 | 1,976,703 | 06-18-2021 |
$33.82 | $33.75 | $33.82 | $33.82 | $33.71 | 1,563,608 | 06-17-2021 |
News, Short Squeeze, Breakout and More Instantly...
Constellation Pharmaceuticals Inc. Company Name:
CNST Stock Symbol:
NASDAQ Market:
Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR) ("MorphoSys") today announced the successful completion of its...
MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), for its tender offer for Constellation P...
Translational data support the disease-modifying potential of pelabresib Central pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib treatment observed across a wide range of myelofibrosis patient subgroups...